To better characterize the association between germline ATM pathogenic variants and the atypical cancers seen in our six patients, we performed a comprehensive review of all cross-sectional studies where germline sequencing was performed in patients diagnosed with carcinomas of the biliary tract, uterus, small bowel and ampulla, kidney, and lung, as well as sarcomas. This evidence concerns the gene ATM and cancer.